Business Description
FIT Biotech Oy
ISIN : FI4000148606
Description
FIT Biotech Oy is a clinical-stage biotechnology company. It is primarily focused on developing antibody therapies for cancer immunotherapy as well as Deoxyribonucleic acid (DNA) vaccines for the prevention of infectious diseases such as Human immunodeficiency virus (HIV). The firm's GTU technology enables the production of antibodies in the human body instead of using industrially manufactured antibodies. The GTU technology platform has various application areas. The group generates revenue through the sales of services related to the HIV vaccine. The organization is based in Finland.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | -8.69 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 0.06 | |||||
| Beneish M-Score | -7.44 | |||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 14-Day RSI | 47.54 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.53 | |||||
| Quick Ratio | 0.53 | |||||
| Days Payable | 1 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -1440 | |||||
| Operating Margin % | -28750 | |||||
| Net Margin % | -35550 | |||||
| FCF Margin % | -27950 | |||||
| ROA % | -265.1 | |||||
| ROIC % | -960.47 | |||||
| ROC (Joel Greenblatt) % | -3291.98 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-Revenue | 1353.9 | |||||
| Earnings Yield (Greenblatt) % | -21.2 | |||||
| FCF Yield % | -707.99 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
FIT Biotech Oy Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.01 | ||
| EPS (TTM) (€) | -0.1 | ||
| Beta | 0 | ||
| Volatility % | 91.49 | ||
| 14-Day RSI | 47.54 | ||
| 14-Day ATR (€) | 0 | ||
| 20-Day SMA (€) | 0.01 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (€) | 0 - 0 | ||
| Shares Outstanding (Mil) | 3,415.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
FIT Biotech Oy Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
FIT Biotech Oy Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
FIT Biotech Oy Frequently Asked Questions
What is FIT Biotech Oy(OHEL:FITBIO)'s stock price today?
The current price of OHEL:FITBIO is €0.00. The 52 week high of OHEL:FITBIO is €0.00 and 52 week low is €0.00.
When is next earnings date of FIT Biotech Oy(OHEL:FITBIO)?
The next earnings date of FIT Biotech Oy(OHEL:FITBIO) is .
Does FIT Biotech Oy(OHEL:FITBIO) pay dividends? If so, how much?
FIT Biotech Oy(OHEL:FITBIO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers